Skip to main content
S&P 5007,720.39-0.30%DOW52,342.56-0.25%NASDAQ26,184.72-1.38%BTC$77,045.00-4.95%ETH$2,215.83-5.85%GOLD$4,026.60-0.12%OIL$102.79+0.77%
Smart Investors Daily
SID Premium
Medtronic plc logo

NYSE · MDT

Medtronic plc

Healthcare · Medical - Devices

$97.11

Up+$2.33 (+2.46%)

Updated Oct 30, 2026, 7:16 AM

SID Score

6.6/10

Composite research score

Smart Money

35/100

Bearish

Market cap
127.94B
P/E ratio
26.83
Dividend yield
3.64%
52-week range
$73.31 – $105.50
Volume
9.38M
Avg. volume
7.16M

Price performance · MDT

MDT price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

MDT closed at $97.11 after 21 trading sessions, up 12.34% for the selected period.

Last close
$97.11
Period change
+12.34%
Period low
$85.51
Period high
$97.11
Daily close
View OHLC price history
MDT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$96.47$97.195$95.17$97.119.38M
Oct 28, 2026$93.06$95.715$93.0401$94.789.58M
Oct 27, 2026$94.25$94.53$93.74$93.955.45M
Oct 26, 2026$95.00$95.70$94.09$94.798.46M
Oct 23, 2026$96.10$96.89$95.38$95.416.01M
Oct 22, 2026$93.48$96.66$93.12$96.598.88M
Oct 21, 2026$93.25$95.30$92.71$93.0311.51M
Oct 20, 2026$93.525$94.92$93.42$94.6314.85M
Oct 19, 2026$93.80$94.80$92.67$92.7723.01M
Oct 16, 2026$95.83$96.50$94.26$94.7530.27M
Oct 15, 2026$95.00$96.24$93.9588$95.4550.23M
Oct 14, 2026$93.01$94.72$92.16$94.2349.86M
Oct 13, 2026$92.35$93.01$90.20$93.0124.93M
Oct 12, 2026$90.76$92.87$90.71$91.9336.56M
Oct 9, 2026$88.49$89.805$87.40$88.4838.86M
Oct 8, 2026$85.90$88.475$85.55$87.75105.66M
Oct 7, 2026$87.40$88.19$85.425$85.5155.89M
Oct 6, 2026$87.97$88.50$86.445$87.0952.14M
Oct 5, 2026$86.33$88.12$85.5276$87.9743.69M
Oct 2, 2026$86.55$87.94$85.59$86.3835.37M
Oct 1, 2026$85.85$86.84$85.22$86.4429.28M

Latest MDT news

The latest Smart Investors Daily articles mentioning MDT.

Stock researchCompany · Overview

MDT research

Overview

Company profile and research snapshot.

Company profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$111.50
Implied upside
—
Analysts
22
MDT recent ratings
DateFirmRatingTarget
Oct 12, 2026BTIGBuy—
Oct 7, 2026BarclaysEqual-Weight—
Sep 30, 2026TD CowenBuy—
Sep 3, 2026UBSBuy—
Sep 2, 2026Truist SecuritiesHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 24, 2026

Medtronic (MDT) Reports Strong Real World Ablation Data At APHRS 2026

Medtronic (NYSE:MDT) reported positive real world registry results for its Sphere-9 catheter and PulseSelect PFA System at APHRS 2026. The Sphere-9 catheter data covered both atrial and ventricular arrhythmias, with registry outcomes indicating high procedural success rates. PulseSelect PFA System findings highlighted a strong safety profile in everyday clinical use, beyond controlled trial settings. The Sphere-9 and PulseSelect registry findings matter, but investors should weigh more than...

Yahoo · Oct 24, 2026

Medtronic (MDT) Stock Could Be A Bargain On Cash Flow

Medtronic has delivered a solid 51.6% share price gain over the past three years, while rolling out new cardiac devices and digital tools that could reshape how it earns and collects cash. With the stock around US$95.41, the open question is whether that price tag lines up with what the company’s cash flows can reasonably support. The 51.6% return over three years puts real weight on the issue of whether Medtronic’s current valuation can still be explained by its underlying cash...

Yahoo · Oct 23, 2026

Global Access Device Market Size, Share, Trends, and Forecast, 2026-2032: Trocar and Single-Port Access Devices | Market to Exceed $1.2 Billion as Advanced Trocars Drive Growth

New Report available from Research and Markets, values access devices at just over $990m in 2025, led by Applied Medical, Ethicon and Medtronic — though reprocessing contracts and cheap Asia-Pacific disposables keep prices under pressureDublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Access Device Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Trocar and Single-Port Access Devices" has been added to ResearchAndMarkets.com's offering. Global Access Device Market to Exceed $1.2 B

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By